Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeNYSE:JNJ

      NYSE:JNJ

      Is Johnson & Johnson (Jnj) Stock Alpha Enough to Make It a Good Low Beta Stock?
      Investing News

      Is Johnson & Johnson (Jnj) Stock Alpha Enough to Make It a Good Low Beta Stock?

      October 19, 2022
      Johnson and Johnson Stock Went Up After the Company Said It Would Report Earnings for the Third Quarter
      Investing News

      Johnson and Johnson Stock Went Up After the Company Said It Would Report Earnings for the Third Quarter

      October 17, 2022
      JNJ Stock Fell as Long-Term Ulcerative Colitis Therapeutic Effects Were Highlighted.
      Investing News

      JNJ Stock Fell as Long-Term Ulcerative Colitis Therapeutic Effects Were Highlighted.

      October 10, 2022
      Jnj Stock Rises as Kenvue Is the Name Given to Its Consumer Health Offshoot
      Investing News

      Jnj Stock Rises as Kenvue Is the Name Given to Its Consumer Health Offshoot

      September 28, 2022
      Three Long Term Dividend Stocks to Buy
      Investing News

      Three Long Term Dividend Stocks to Buy

      September 15, 2022
      Johnson & Johnson (JNJ) Stock: A High-Value Dividend Stock
      Investing News

      Johnson & Johnson (JNJ) Stock: A High-Value Dividend Stock

      September 15, 2022
      Johnson & Johnson stock rose with the announcement of a $5 billion share buyback program and repeated profit targets.
      Investing News

      Johnson & Johnson stock rose with the announcement of a $5 billion share buyback program and repeated profit targets.

      September 14, 2022
      Pfizer Sets Eyes On $10 billion+ Opportunity For RSV Vaccines 
      Investing News

      Pfizer Sets Eyes On $10 billion+ Opportunity For RSV Vaccines 

      August 29, 2022
      The EC has approved J&J’s Tecvayli for the treatment of multiple myeloma.
      Investing News

      The EC has approved J&J’s Tecvayli for the treatment of multiple myeloma.

      August 25, 2022
      Johnson & Johnson attempts to extend its “Texas two-step” in order to end talc litigation in two states
      Investing News

      Johnson & Johnson attempts to extend its “Texas two-step” in order to end talc litigation in two states

      August 22, 2022
      « 1 2 3 »

       

      LATEST NEWS

      • Investing News HP to Cut 6,000 Jobs Amid Restructuring
      • Investing News Dell’s Q3 2026 Earnings Analysis
      • Investing News Workday Q3 Earnings Report 2026 Insights
      • Investing News Alibaba’s AI Boosts Cloud Sales
      • Investing News Best Buy Q3 2026 Earnings Report Insights

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025